losartan potassium

This page contains recent news articles, when available, and an overview of losartan potassium but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Merck Announces Third-Quarter 2009 Financial Results  -  ‎Oct 22, 2009‎
Global sales of Merck's antihypertensive medicines, COZAAR (losartan potassium) and HYZAAR3 (losartan potassium and hydrochlorothiazide), were $861 million ... Reuters

Zydus gets USFDA approval for Losartan Potassium tabs  -  Apr 20, 2007
Mumbai, Apr 20 (PTI) Cadila Healthcare has received tentative approval from the USFDA for Losartan Potassium Tablets, a hypertension drug, ... Free with registration - PTI - The Press Trust of India Ltd - AccessMyLibrary.com

Aurobindo Pharma gets tentative approval for Losartan Potassium  -  Aug 22, 2008
Aurobindo Pharma Limited, one of the country's leading pharmaceutical companies has received the tentative approval from the US Food and Drug Administration ... TopNews

Aurobindo gets USFDA nod for hypertension drug  -  Aug 21, 2008
Losartan Potassium tablets are generic equivalent of Merck Research Laboratories Cozaar tablets of the equal strengths, the company said adding that it is ... Livemint

Teva Announces Tentative Approval of Losartan Potassium & …  -  Jun 14, 2006
JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the US Food and Drug Administration has granted tentative approval for ... Free with registration - Business Wire - AccessMyLibrary.com

For Patients with Hypertension and Left Ventricular Hypertrophy, FDA ...  -  Apr 18, 2005
HYZAAR is the fixed dose combination of COZAAR (losartan potassium) and hydrochlorothiazide. The FDA approved this indication for HYZAAR based on: ... Medical News Today - Medical News Today (press release)

Zydus recieves approval from USFDA  -  May 15, 2008
Losartan Potassium and Hydrochlorthiazide Tablets, an anti-hypertensive, was estimated at $785 million and that of Anastrazole Tablets, a hormone therapy to ... Business Standard

Article: Merck's Hyzaar receives clearance for new indication.(RX/ …  -  May 2, 2005
Hyzaar is the fixed-dose combination of Cozaar (losartan potassium) and ... BUSINESS WIRE)--April 18, 1995--Cozaar (losartan potassium tablets), ... Pay-Per-View - Chain Drug Review - HighBeam Research

FDA Approves HYZAAR As the First and Only Fixed-Dose Combination …  -  Apr 14, 2005
HYZAAR is the fixed dose combination of COZAAR (losartan potassium) and hydrochlorothiazide. The FDA approved this indication for HYZAAR based on: ... RedOrbit

Market Live from BSE - NSE, Latest Market Commentary | Economic …  -  May 15, 2008
Losartan potassium and nydrochiorthiazide Tablets, an anti-hypertensive, was estimated at $785 million and that of anastrazole tablets, a hormone therapy to ... Economic Times

FDA Approves HYZAAR(R) as First/Only Fixed-Dose Combination …  -  May 16, 2005
HYZAAR is the fixed dose combination of COZAAR (losartan potassium) and hydrochlorothiazide. The FDA approved this indication for HYZAAR based on: ... Medical News Today - Medical News Today (press release)

Closing Bell- Market Live-Stocks-Markets-The Economic Times  -  Aug 21, 2008
Losartan Potassium tablets are the generic equivalent of Merck Research Laboratories cozaar tablets 25mg, 50mg and 100mg and falls in the anti-hypertensive ... Economic Times

Article: FDA tentative generics approvals--2006.(Special Report)(List)...  -  Feb 19, 2007
Losartan potassium tablets, 25 mg, Teva Pharmaceuticals5/24/2006 50 mg and 100 mg USA Efavirenztablets, 600 mg Cipla Ltd. 5/24/2006 Losartan potassium ... Pay-Per-View - Chain Drug Review - HighBeam Research

HYZAAR(R) 100-12.5 mg Offers A New Convenient Dosing Option Within …  -  Oct 21, 2005
In other clinical trials with losartan potassium-hydrochlorothiazide the most ... Losartan potassium, a non-peptide molecule, is chemically described as ... $4.95 - Business Wire - ECNext

Chuikyo adds 17 new drugs to Japan's NHI list, including seven NCEs.(...  -  Dec 4, 2006
The price of Banyu Pharmaceutical's Preminent (losartan potassium/hydrochlorothiazide) tablets was set at 190 yen based on the similar comparison method ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

FDA Approves HYZAAR as the First and Only Fixed-Dose Combination …  -  Apr 14, 2005
HYZAAR is the fixed dose combination of COZAAR (losartan potassium) and ... In other clinical trials with losartan potassium-hydrochlorothiazide, ... $4.95 - Business Wire - ECNext

Company Profile Report  -  Apr 5, 2008
Hyzaar (Losartan Potassium/Hydrochlorothiazide) ... Cozaar (Losartan Potassium). Non-Insulin Dependent Diabetes Mellitus (NIDDM)/Type 2 Diabetes ... $50.00 - Revere Reports - Revere

International Approvals: Hyzaar, Glucomed/Flexove, Diacol  -  Dec 19, 2006
December 19, 2006 — Health Canada has approved an expanded indication for losartan potassium plus hydrochlorothiazide 50-mg/12.5-mg tablets and 100-mg/25-mg ... Medscape

Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry …  -  May 31, 2007
Zidovudine Lamotrigine (multiple dosage forms) Leflunomide Liothyronine Sodium Losartan Potassium M Mefloquine HCl Meloxicam (multiple dosage forms) ... Pay-Per-View - Federal Register 2007 - Loislaw

Titration-Extension Study Shows Losartan-Based Treatment Significantly...  -  Oct 24, 2005
...demonstrated that the approach of using Cozaar(R) (losartan potassium), Hyzaar(R) (losartan potassium/ hydrochlorothiazide), and Hyzaar(R)DS (losartan ... DG News

FDA Approvals: Hyzaar, Panzem, Decapinol  -  Apr 21, 2005
On April 5, the FDA approved a new indication for losartan potassium plus ... Losartan potassium plus HCTZ fixed-dose combination tablets were previously ... Medscape

Article: New dosing.(RXs)(Brief article) - Chain Drug Review |...  -  Apr 23, 2007
...s Hyzaar (losartan potassium/hydrochlorothiazide tablets) has been approved to enhance titration options in hypertensive patients. ... Pay-Per-View - Chain Drug Review - HighBeam Research

Merger and Acquisition Scenario  -  Dec 16, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jan 27, 2007
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 15, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merck Reports Second-Quarter 2008 Financial Results  -  Jul 21, 2008
Worldwide sales of Merck's antihypertensive medicines COZAAR (losartan potassium) and HYZAAR(3) (losartan potassium and hydrochlorothiazide) were $941 ... Genetic Engineering News - Genetic Engineering News (press release)

FDA Approvals: Hyzaar, Levemir, NovoLog/Novolin R  -  Oct 27, 2005
Oct. 27, 2005 -- The US Food and Drug Administration (FDA) has approved a new dose for losartan potassium plus hydrochlorothiazide tablets to facilitate ... Medscape

Merger and Acquisition Scenario  -  Aug 19, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Factiva Search  -  Aug 18, 2006
New and generic drug approvals: Losartan Potassium & Hydrochlorothiazide Tablets. 18 August, 2006 US Food and Drug Administration News ... Pay-Per-View - US Food and Drug Administration News - Factiva, from Dow Jones

Merger and Acquisition Scenario  -  Oct 21, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Nov 25, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Aug 19, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Jun 24, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

▒▒ 매�?�경제 / �?권센터 ▒▒  -  Dec 16, 2008
...한편 지난 달 초 출시�?� '코�?'(고혈압치료제, 성분명: losartan potassium) 제네릭 ... 지난 11월'losartan potassium'성분�?� �?외처방 조제액�?� 60억�?으로 전년�?�기 ... 매�?�경제

Merger and Acquisition Scenario  -  May 13, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

광�?�제약�?� '로살탄 칼륨(Losartan potassium)' 성분�?� ARB 고혈압치료제...  -  Dec 3, 2008
...'케�?�살탄 정'�?� 주성분�?� '로살탄'�?� 우수한 혈압강화 효과를 나타내며, 고혈압�?� 있는 제 2형 당뇨병 환�?�?� 신질환�?�?� �?�?��?�?� 가지고 있다. ... 메디�?�뉴스

Merger and Acquisition Scenario  -  Dec 16, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

중외제약 글루패스트, 올메�? 등 무혈입성?  -  Dec 31, 2008
...�?�와 함께 Losartan potassium 100mg�?� 경우 오잘탄정 100mg(한미약품),코�?정100mg( 한국 엠�?스디),코�?르탄정100mg(�?�아제약),살로탄정100mg(종근당)등 4품목�?� 경합 ... 아�?�비타임즈

Merger and Acquisition Scenario  -  Nov 4, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Sep 2, 2006
...for prevention of osteoporosis; Cozaar (losartan potassium)/Hyzaar (losartan potassium and hydrochlorothiazide) and Vasotec (enalapril maleate), ... $250.00 - Revere Reports - Revere

EU Panel Backs Wider Approval Of Merck's Erbitux  -  Oct 24, 2008
...and associated names (losartan potassium), from Merck Sharp & Dohme BV, to add a paediatric formulation of powder and solvent for oral suspension. ... Capital.gr

Stadmed Private Limited: Ensuring Wellness  -  Oct 15, 2007
In the cardiac sector, the recent addition is Losartan Potassium Plain and with Hydrocholothiazide combination. In the diabetic segment, Stadmed has added ... Express Pharma

Zydus Cadila Q1 net profit up by 27%  -  Aug 1, 2007
The group received tentative approvals for Losartan Potassium, Topiramate and Amplodipine Besylate Tablets and approvals for Benzonatate Capsules and ... Moneycontrol.com

Merck Raises Sales Forecast on Strong Earnings Report  -  Aug 1, 2007
Forecasts for allergy medicine Singulair (montelukast sodium) and hypertension treatment Cozaar (losartan potassium) were each increased by $100 million to ... FDA news - FDA news (subscription)

�?i�?u trị máu nhiễm mỡ  -  Sep 8, 2008
Xin h�?i có thể dùng Losartan Potassium và Lopid trong đi�?u trị được không ? ... Losartan Potassium là thuốc chỉ định làm hạ huyết áp cao chứ không đi�?u trị ... VNMedia

New indications.(Rx)(restless legs syndrome can be cured by …  -  Jun 6, 2005
A new indication for Hyzaar (losartan potassium/ hydrochlorothiazide) has been cleared for Merck & Co., Whitehouse Station, NJ, (908) 423-1000. ... Free with registration - Drug Topics - AccessMyLibrary.com

Force of blood  -  Nov 12, 2006
Currently, there are seven angiotensin II receptor antagonists: valsartan, candesartan, eprosartan, irbesartan, losartan potassium, olmesartan, ... Malaysia Star

FDA okays Teva blood pressure drug  -  Jun 15, 2006
Final permission to sell tablets containing the drug's active ingredients, losartan potassium and hydrochlorothiazide is expected when Merck's patent ... Jerusalem Post

Federal Register 2007 - 72 FR 60683 Publication of Guidances for …  -  Oct 25, 2007
...corrected the analytes to measure (3) Erlotinib HCl tablet, deleted the IND requirement (4) Hydrochlorothiazide and losartan potassium tablets, ... Pay-Per-View - Federal Register 2007 - Loislaw

Article: Teva gets tentative OK for generic blood-pressure medicine. ...  -  Jun 14, 2006
Hyzaar, also known by the chemical name losartan potassium and hydrochlorothiazide, is used to reduce stroke in patients with high blood pressure. ... Pay-Per-View - Philadelphia Inquirer - HighBeam Research

OTC: New prescription products - Cozaar Comp 100/25.(Merck Sharp and …  -  Dec 3, 2005
Tablets containing losartan potassium 100mg and hydrochlorothiazide 25mg. For the treatment of hypertension in patients whose blood pressure has been ... Free with registration - Chemist & Druggist - AccessMyLibrary.com

Chan cited in two 483 violations for faulty informed consent procedure...  -  Sep 1, 2005
The report also noted that Chan's clinical research involves evaluating the safety and efficacy of losartan potassium for the treatment of type-2 diabetes. ... Free with registration - Bioresearch Monitoring Alert - AccessMyLibrary.com

Blood Pressure Med Prevents Aortic Aneurysm in Mice with Marfan …  -  Apr 4, 2006
The medication used in this study, formally known as losartan potassium, is part of a class of medications called angiotensin II receptor antagonists, ... newswise.com

Brands vs Generics  -  Feb 17, 2008
Even some of the life-long prescription drugs like Clopidogrel, Losartan Potassium, Atorvastatin, Simvastatin, Captopril, Omeprazole, etc are available in ... Sunday Times.lk

Losartan Prevents Life-threatening Insulin Resistance In Burn Injuries  -  Apr 11, 2006
Funding: Merck & Co., Inc. and DuPont Co. provided losartan potassium. Go to http://www.faseb.org/meetings/eb2006/call/ and click on "Searchable Program ... Medical News Today - Medical News Today (press release)

Losartan Prevents Insulin Resistance from Burns  -  Mar 31, 2006
Funding: Merck & Co., Inc. and DuPont Co. provided losartan potassium. Go to http://www.faseb.org/meetings/eb2006/call/ and click on "Searchable Program ... newswise.com

Roopa Industries to issue convertible warrants  -  Feb 11, 2008
The company`s products include triphenyl phosphine, fluconazole, and losartan potassium. Roopa Industries has its plant located at Patancheru, ... Myiris.com

Hypertension; Majority of hypertensive patients will require combinati...  -  Apr 26, 2005
...medoxomil (32.4%) compared with recommended starting doses of losartan potassium (16.1%), valsartan (14.5%), or irbesartan (25.9%)," they reported. ... Pay-Per-View - Science Letter - Factiva, from Dow Jones

Teva Announces Tentative Approval for Generic Cozaar(R) Tablets.  -  May 28, 2006
Drug Application (ANDA) to market its generic version of Merck's antihypertensive agent Cozaar(R) (Losartan Potassium) Tablets, 25 mg, 50 mg and 100 mg. ... Free with registration - Business Wire - AccessMyLibrary.com

US nod to four Zydus Cadilla drugs  -  May 15, 2008
The company quoted NDC to say that the hormonal therapy drug Anastrazole has an estimated market of $13 million and the anti-hypertensive Losartan Potassium ... Siliconindia.com

Research and Markets: Examine Financial Performance of Merck & Co …  -  Oct 9, 2006
Cozaar (losartan potassium) was the first angiotensin-II receptor antagonist selective for AT1 receptors to be developed for the treatment of hypertension. ... Genetic Engineering News - Genetic Engineering News (press release)

Research and Markets: Examine Financial Performance of Merck & Co …  -  Sep 10, 2006
Cozaar (losartan potassium) was the first angiotensin-II receptor antagonist selective for AT1 receptors to be developed for the treatment of hypertension. ... FinanzNachrichten.de

Nippon Organon: Marvelon 28 Low-dose Oral Contraceptive  -  Dec 25, 2006
It is a combination of the angiotensin II receptor blocker (ARB) losartan potassium (Nu-lotan) and the thiazide diuretic hydrochlorothiazide. ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones

New dosage strengths.(RX)(Brief article)  -  Nov 21, 2005
...is introducing Hyzaar tablets, in 100/12.5- mg dosage strength, combining the once-daily efficacy of 100-mg Cozaar (losartan potassium) with a. $4.95 - Drug Topics - ECNext

▒종합 경제정보 미디어 - �?��?��?�리▒  -  Oct 29, 2008
...오잘탄'�?� '로살탄 �?�타슘(Losartan potassium)'�?� 주성분으로 하는 것으로, 한국MSD �?� 고혈압치료제 '코�?'�?� 복제약�?�다. 한국MSD�?� '코�?'는 연간 780억�? 규모며, ... �?��?��?�리

Factiva Search  -  Dec 3, 2005
Tablets containing losartan potassium 100mg and hydrochlorothiazide 25mg. For the treatment of hypertension in patients ... (c) 2005 CMP Information Ltd. ... Pay-Per-View - Chemist & Druggist - Factiva, from Dow Jones

טבע קיבלה �?ישור לתרופה לטיפול ביתר לחץ ד�?  -  Jun 14, 2006
...קוז�?ר הי�? תרופה הדומה להייז�?ר, ומכילה Losartan Potassium ג�? כן, �?ול�? ל�? מכילה הידרוכלורותי�?זיד ... ynet ידיעות �?חרונות - ynet ידיעות �?חרונות

טבע: �?ישור לגרסה גנרית של תרופת לוס�?רט�?ן  -  May 28, 2006
...טבע תייצר גרסה גנרית לתרופה המקורית לוס�?רט�?ן (Losartan Potassium) המיוצרת על ידי חברת התרופות ... ynet ידיעות �?חרונות - ynet ידיעות �?חרונות

בורסה: ת"�? 100 עלה ב-1.2%; הדולר: 4.4600 ש'  -  Jun 15, 2006
...מניית טבע נסחרה על רקע קבלת �?ישור טנטטיבי ה-FDA לשיווק טבליות Losartan Potassium Hydrochlorothiazide ... ynet ידיעות �?חרונות - ynet ידיעות �?חרונות

הבורסה ננעלה בעליות שערי�?  -  May 29, 2006
...טבע תייצר גרסה גנרית לתרופה המקורית לוס�?רט�?ן (Losartan Potassium) המיוצרת על ידי חברת התרופות ... ynet ידיעות �?חרונות - ynet ידיעות �?חרונות

New dosage strengths.  -  Nov 21, 2005
...combining the once-daily efficacy of 100-mg Cozaar (losartan potassium) with a low-dose diuretic to offer another losartan titration option. ... $9.94 - Drug Topics - Alacra Store

Scriptlines: Cozaar 28s.(product introduction)(Brief Article)  -  Jul 23, 2005
Merck Sharp & Dohme has launched a 28-day pack of Cozaar 25mg tablets (losartan potassium). Price: 28 tablets #18.09 Pip code: 317-0347 Merck Sharp & Dohme ... $4.95 - Chemist & Druggist - ECNext

24 New Drugs Approved  -  Nov 6, 2006
Banyu Pharmaceutical has obtained approval for the combination drug for hypertension PREMINENT (losartan potassium + hydrochlorothiazide). ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones

New indications.  -  May 2, 2005
A new indication for Hyzaar (losartan potassium/ hydrochlorothiazide) has been cleared for Merck & Co., Whitehouse Station, N.J., (908) 423-1000. ... $9.94 - Drug Topics - Alacra Store

Hypertension; Majority of hypertensive patients will require combinati...  -  Apr 30, 2005
...medoxomil (32.4%) compared with recommended starting doses of losartan potassium (16.1%), valsartan (14.5%), or irbesartan (25.9%)," they reported. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Eight APIs recommended for approval. [1 table in original article]  -  Sep 4, 2006
The product combines losartan potassium (an angiotensin receptor 2 blocker) with hydrochlorothiazide (a diuretic). It is designed for the treatment of ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones

Lipitor receives clearance in Canada.(Brief article) | Article from...  -  Mar 27, 2006
...s fixed-dose combination antihypertensive drug Hyzaar (losartan potassium-hydrochlorothiazide tablets). Hyzaar is now indicated to reduce the risk of stroke ... Pay-Per-View - Chain Drug Review - HighBeam Research

OTC: New prescription products - Cozaar Comp 100/25.(Merck Sharp and …  -  Dec 3, 2005
Tablets containing losartan potassium 100mg and hydrochlorothiazide 25mg. Usual dose: one tablet daily. Merck Sharp & Dohme Ltd. Tel: 01992 467272 ... $4.95 - Chemist & Druggist - ECNext

Hypertension; New research in the area of hypertension detailed  -  Jul 26, 2005
...medoxomil (32.4%) compared with recommended starting doses of losartan potassium (16.1%), valsartan (14.5%), or irbesartan (25.9%)," they reported. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones

Banyu Begins Detailing Preminent, a Combination Drug for Hypertension  -  Dec 11, 2006
Banyu Pharmaceutical has initiated detailing activities for the hypertension treatment Preminent (losartan potassium + hydrochlorothiazide). ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones

ACME LABORATORIES LTD.  -  Mar 1, 2008
...combination of Losartan potassium 50 mg and Hydrochlorothiazide 12.5 mg. The company's. Losart Plus tablet could be used for the treatment of hypertension. ... $3,450.00 - GLOBAL INDUSTRY ANALYSTS KEY PLAYERS - Alacra Store

Pollutant particles produce vasoconstriction and enhance MAPK …  -  Aug 1, 2005
...(San Diego, CA); and losartan potassium from Merck & Co., Inc. (West Point, PA). Monoclonal antibodies against phospho-p38, total extracellular ... $4.95 - Environmental Health Perspectives - ECNext

NO1.뉴미디어'마�?��?��?�리  -  Dec 3, 2008
...［메디컬투�?��?� 권선미 기�?］ 광�?�제약�?� '로살탄 칼륨(Losartan potassium)' 성분 �?� ARB 고혈압치료제 '케�?�살탄 정'�?� 발매했다고 3�?� �?혔다. ... 마�?��?��?�리

시�?�?� 있는 �?�약전문 �?�터넷신문-메디파나뉴스  -  Jan 4, 2006
...광�?�제약(회장 최수부)�?� '로살탄 칼륨(Losartan potassium)' 성분�?� ARB 고혈압 치료제 '케�?�살탄정'�?� 발매했다. '케�?�살탄정'�?� 주성분�?� 로살탄�?� 우수한 혈압강화 ... 메디파나뉴스

וול סטריט: נ�?סד"ק עלה בכ-0.7% �?חרי צניחה של 12% בחודש; ט�?ו�?ר קפצה  -  Jun 14, 2006
...מרשות המזון והתרופות ה�?מריק�?ית (FDA) לשווק טבליות Losartan Potassium & Hydrochlorothiazide בחוזקי�? של 50 ... ה�?רץ

וול סטריט סגרה בעליות למרות ספר הבז' ונתון הליבה  -  Jun 14, 2006
...�?ת הגירסה הגנרית לטבליות של חברת מרק (losartan potassium & hydrochlorothiazide) לטיפול בלחץ ד�? גבוה. ... Bizportal

시�?�?� 있는 �?�약전문 �?�터넷신문-메디파나뉴스  -  Jan 4, 2006
...주성분�?� 로살탄 �?�타슘(Losartan potassium, �?�하 로살탄)�?� 오잘탄�?� 한미약품�?� 제법기술(특허 제10-0809159호)�?� �?용해 �?료합성�? 성공한 순수 국산�?�약품으로 ... 메디파나뉴스

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.